COVID-19: continuity and resilience
policy
trade
COVID-19 Enterprise Resilience Framework
Resilient enterprise
Our framework identifies nine areas businesses can address to build a structured and comprehensive approach to crisis management and business resilience.
Navigate the nine dimensions of our framework, or find out more about our Enterprise Resilience Tool.
Read More
Employee health and wellbeing
What matters most:
- Promoting employee safety and wellbeing
- Public health information
- Support for impacted employees
Talent and workforce
Customer and brand
What matters most:
- Safety-based customer experience
- Direct to consumer and e-retail
- Packaging and delivery innovation
Financial and investor
What matters most:
- Liquidity, cash flow, credit and capital
- Regulatory/disclosures
- Investor trust
- Tax strategies and tax accounting
Risk
What matters most:
- Enterprise risk planning
- Risk identification
- Scenario planning
- Continuity and recovery
- Response and monitoring
Government and public policy
What matters most:
- Geopolitical risks
- Country risks
- Regulatory changes
- Leadership and public policy engagement
- Sustainability
Technology and infosec
Insurance and legal disputes
What matters most:
- Business interruption
- Supply chain claims
- Legal and contract disputes
- Event cancellation
Supply chain and global trade
What matters most:
- Supply chain resilience
- Third-party service providers
- Sustainability
Employee health and wellbeing
What matters most:
- Promoting employee safety and wellbeing
- Public health information
- Support for impacted employees
Talent and workforce
What matters most:
- Employee relations
- Talent initiatives
- Business traveller
Customer and brand
What matters most:
- Safety-based customer experience
- Direct to consumer and e-retail
- Packaging and delivery innovation
Financial and investor
What matters most:
- Liquidity, cash flow, credit and capital
- Regulatory/disclosures
- Investor trust
- Tax strategies and tax accounting
Risk
What matters most:
- Enterprise risk planning
- Risk identification
- Scenario planning
- Continuity and recovery
- Response and monitoring
Government and public policy
What matters most:
- Geopolitical risks
- Country risks
- Regulatory changes
- Leadership and public policy engagement
- Sustainability
Technology and infosec
What matters most:
- Infrastructure framework
- Cyber resilience
- Digital customer channels
Insurance and legal disputes
What matters most:
- Business interruption
- Supply chain claims
- Legal and contract disputes
- Event cancellation
Supply chain and global trade
What matters most:
- Supply chain resilience
- Third-party service providers
- Sustainability
In challenging times, we’re #BetterTogether to build a better working world.
Through actions both big and small, our people are helping each other, clients and society tackle COVID-19 challenges and build an even better working world.
Dr. Kiran Mazumdar-Shaw, Biocon, is EY World Entrepreneur Of The Year™ 2020
This year’s winner is a trailblazer who turned a US$500 investment into one of Asia’s leading biotech companies.
Featured press releases
Pharmaceutical companies grew significantly in 2019 – the coronavirus crisis is bringing learning effects for the future
Zurich, 24 June 2020. The largest pharmaceutical companies in the world picked up speed again in 2019 after a break in growth in the previous year and, in particular, increased their innovation efforts.
24 Jun 2020 Zurich CH
Massive decline in foreign direct investment expected in Switzerland and Europe
Zurich, 19 June 2020. Last year Europe was able to assert itself as an attractive investment location and attract a total of 6,412 investment projects from foreign companies. That is one per cent more than in 2018 and the second highest level ever measured.
19 Jun 2020 Zurich CH
Covid-19 presents European start-up companies with an existential challenge
Zurich, 21 April 2020. After record levels of financing last year, a massive slump in start-up financing is now expected for 2020 due to the current coronavirus crisis.
21 Apr 2020 Zurich CH
Feed
Join EY in conversation
On the agenda (11)
Next
